MedPath

Gamete Treatment to Correct Fertilization Failure

Not Applicable
Recruiting
Conditions
Infertility
Registration Number
NCT01944332
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

In this proposed research study, the investigators plan to assess the efficacy of gametes' (egg and sperm) treatment on fertilization as well as pre- and post-implantation embryo development.

Detailed Description

The spermatozoa will be prepared in the standard fashion and utilized for injection after exposure to a membrane permeabilizing agent. The raw sperm specimen may be selected through a synthetic, sterile, single-use, culture-tested mesh. The specimen will then be placed in a 37°C environment. After 30 minutes, the selected portion is retrieved from the other side of the mesh. The spermatozoa will be prepared in the standard fashion will be utilized for injection or intrauterine insemination. Human recombinant PLC-zeta will also be used if the spermatozoa have been confirmed to be PLC-zeta deficient.

The injected oocytes will be then exposed to the previously mentioned activating agents for the purpose of inducing embryo development. The successfully fertilized oocytes will be further kept in culture for up to 5 days as per standard IVF/ICSI. Results in terms of fertilization and embryo cleavage will be assessed and monitored for the remainder of the culture period. Developing embryos selected according to standard criteria will be replaced to the patient or will be cryopreserved.

Because fertilization failure carries such a high emotional and financial toll on our patients, at the present time, the only method to generate an embryo for these cases is to perform assisted oocyte activation in conjunction with ICSI. The research intervention - assisted oocyte activation - is believed to help alleviate the failed fertilization by obtaining some zygotes for the patient. In these cases of complete failed fertilization, intracytoplasmic sperm injection (ICSI) will be performed as a routine clinical treatment even if they are not enrolled in the study. After several failures, their reproductive physician may recommend the use of donor spermatozoa instead of the male partner's.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1200
Inclusion Criteria
  • Patients with complete fertilization failure with standard IVF or failure with one prior ICSI treatment cycle
Exclusion Criteria
  • not meeting inclusion criteria
  • IVF without ICSI

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Fertilization rate2 months

Efficacy of gamete treatment on fertilization

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Center fo Reproductive Medicine

🇺🇸

New York, New York, United States

Center fo Reproductive Medicine
🇺🇸New York, New York, United States
Rodriq Stubbs, NP
Contact
646-962-3276
res2011@med.cornell.edu
Iman Mohammed, MPA
Contact
646-962-3274
ibm4001@med.cornell.edu
Gianpiero Palermo, MD, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.